European Journal of Cancer最新文献

筛选
英文 中文
8 Oral: ALTA3263: an oral, KRAS isoform-selective, dual ON/OFF state, noncovalent inhibitor induces regressions across KRAS G12V, G12D, and G12C cancer models 8 口服:ALTA3263:一种口服的、具有 KRAS 同工酶选择性的、双重 ON/OFF 状态的非共价抑制剂,可诱导 KRAS G12V、G12D 和 G12C 癌症模型的消退
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114537
T. Wang, M. Ibanez, K. Yu, K. Fan, J. Juan, M. Perez, T. Smith, B. Walsh, V. Kang, J. Tyhonas, N. Alvarez, J. Tran, K.S. Moorefield, A. Phimister, X. Zhu, A. Chi, M.D. Bartberger, E. Murphy
{"title":"8 Oral: ALTA3263: an oral, KRAS isoform-selective, dual ON/OFF state, noncovalent inhibitor induces regressions across KRAS G12V, G12D, and G12C cancer models","authors":"T. Wang, M. Ibanez, K. Yu, K. Fan, J. Juan, M. Perez, T. Smith, B. Walsh, V. Kang, J. Tyhonas, N. Alvarez, J. Tran, K.S. Moorefield, A. Phimister, X. Zhu, A. Chi, M.D. Bartberger, E. Murphy","doi":"10.1016/j.ejca.2024.114537","DOIUrl":"10.1016/j.ejca.2024.114537","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142534546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
32 (PB020): Discovery of novel MTA-cooperative PRMT5 inhibitors as targeted therapeutics for MTAP-deleted cancers 32 (PB020):发现新型 MTA 协作 PRMT5 抑制剂,作为 MTAP 缺失型癌症的靶向治疗药物
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114560
A. Radzimierski, A. Bobowska, A. Stachowicz, K. Kuś, K. Kozłowska-Tomczyk, A. Ludwig-Słomczyńska, A. Gołas, M. Żukowska, G. Ćwiertnia, K. Brzózka, M. Nowak, A. Bartosik, D. Pez
{"title":"32 (PB020): Discovery of novel MTA-cooperative PRMT5 inhibitors as targeted therapeutics for MTAP-deleted cancers","authors":"A. Radzimierski, A. Bobowska, A. Stachowicz, K. Kuś, K. Kozłowska-Tomczyk, A. Ludwig-Słomczyńska, A. Gołas, M. Żukowska, G. Ćwiertnia, K. Brzózka, M. Nowak, A. Bartosik, D. Pez","doi":"10.1016/j.ejca.2024.114560","DOIUrl":"10.1016/j.ejca.2024.114560","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
41 (PB029): Preclinical characterization of ABSK131, a potential best-in-class MTAcooperative PRMT5 inhibitor 41(PB029):潜在的同类最佳 MTA 合作 PRMT5 抑制剂 ABSK131 的临床前表征
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114569
W. Pan, H. Wang, F. Qi, H. Deng, H. Yu, Y.C. Xu, Z. Chen, H. Ying
{"title":"41 (PB029): Preclinical characterization of ABSK131, a potential best-in-class MTAcooperative PRMT5 inhibitor","authors":"W. Pan, H. Wang, F. Qi, H. Deng, H. Yu, Y.C. Xu, Z. Chen, H. Ying","doi":"10.1016/j.ejca.2024.114569","DOIUrl":"10.1016/j.ejca.2024.114569","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
42 (PB030): A novel small-molecule CBP/p300 HAT domain inhibitor demonstrates potent in vivo activity and a favorable safety profile in preclinical species 42 (PB030):一种新型小分子 CBP/p300 HAT 结构域抑制剂在临床前物种中显示出强大的体内活性和良好的安全性特征
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114570
K. Hearn, M. Ahn, L. Bevan, G. Chessari, M. Clark, B. Cons, J. Espana-agusti, K. Ferro, A. Howard, J. Lyons, V. Martins, C. Morgillo, N. Palmer, M. Rapti, A. Shah, T. Smyth, M. Unbekandt, D. Varshney, C. Hamlett
{"title":"42 (PB030): A novel small-molecule CBP/p300 HAT domain inhibitor demonstrates potent in vivo activity and a favorable safety profile in preclinical species","authors":"K. Hearn, M. Ahn, L. Bevan, G. Chessari, M. Clark, B. Cons, J. Espana-agusti, K. Ferro, A. Howard, J. Lyons, V. Martins, C. Morgillo, N. Palmer, M. Rapti, A. Shah, T. Smyth, M. Unbekandt, D. Varshney, C. Hamlett","doi":"10.1016/j.ejca.2024.114570","DOIUrl":"10.1016/j.ejca.2024.114570","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
39 (PB027): TEAD inhibition by SW-682 potentiates activity of targeted therapies in NSCLC models 39 (PB027):SW-682 抑制 TEAD 可增强 NSCLC 模型中靶向疗法的活性
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114567
L. Chen, V. Jové, P. Miliani de Marval, R. DuBose, S. Saha, M. Johnson, S. Ahn, K. Powell, F. Liu, B. Lawhorn, S. Gwaltney, W. Shao, T.A. Lin
{"title":"39 (PB027): TEAD inhibition by SW-682 potentiates activity of targeted therapies in NSCLC models","authors":"L. Chen, V. Jové, P. Miliani de Marval, R. DuBose, S. Saha, M. Johnson, S. Ahn, K. Powell, F. Liu, B. Lawhorn, S. Gwaltney, W. Shao, T.A. Lin","doi":"10.1016/j.ejca.2024.114567","DOIUrl":"10.1016/j.ejca.2024.114567","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
58 (PB046): Tumor-agnostic efficacy and safety of lirafugratinib, a highly selective FGFR2 inhibitor, in patients (pts) with advanced solid tumors with FGFR2 fusions or rearrangements (f/r): the ReFocus study 58 (PB046):高选择性表皮生长因子受体2(FGFR2)融合或重排(f/r)晚期实体瘤患者(pts)中利拉伐替尼(lirafugratinib)的肿瘤诊断疗效和安全性:ReFocus研究
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114585
A. Hollebecque, E. Dotan, C.Y.A. Liao, D. Roda, E. Fontana, H. Babiker, R.D. Kim, D.Y. Oh, F. Ghiringhelli, I. Moreno, J. Liu, V. Subbiah, A. Varkaris, M.J. Borad, P.A. Cassier, A. Deary, F.T. Ramirez, F. Ricard, K.Y. Jen, A.M. Schram
{"title":"58 (PB046): Tumor-agnostic efficacy and safety of lirafugratinib, a highly selective FGFR2 inhibitor, in patients (pts) with advanced solid tumors with FGFR2 fusions or rearrangements (f/r): the ReFocus study","authors":"A. Hollebecque, E. Dotan, C.Y.A. Liao, D. Roda, E. Fontana, H. Babiker, R.D. Kim, D.Y. Oh, F. Ghiringhelli, I. Moreno, J. Liu, V. Subbiah, A. Varkaris, M.J. Borad, P.A. Cassier, A. Deary, F.T. Ramirez, F. Ricard, K.Y. Jen, A.M. Schram","doi":"10.1016/j.ejca.2024.114585","DOIUrl":"10.1016/j.ejca.2024.114585","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
67 (PB055): Combined cellular and biochemical profiling of BTK inhibitor nemtabrutinib reveals potential application in FGFR-driven cancers 67 (PB055):BTK抑制剂nemtabrutinib的细胞和生化综合分析揭示了其在表皮生长因子受体(FGFR)驱动的癌症中的潜在应用
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114594
D. Kluitmans, J. Kooijman, J. Melis, E. van den Bossche, J. Dylus, J. de Roos, G. Zaman
{"title":"67 (PB055): Combined cellular and biochemical profiling of BTK inhibitor nemtabrutinib reveals potential application in FGFR-driven cancers","authors":"D. Kluitmans, J. Kooijman, J. Melis, E. van den Bossche, J. Dylus, J. de Roos, G. Zaman","doi":"10.1016/j.ejca.2024.114594","DOIUrl":"10.1016/j.ejca.2024.114594","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
69 (PB057): A novel and potent MAT2A inhibitor, HM100760, demonstrates antitumor activity in MTAP-deleted cancers 69 (PB057):新型强效 MAT2A 抑制剂 HM100760 在 MTAP 缺失的癌症中显示出抗肿瘤活性
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114596
E.J. Kwak, S.H. Jung, D.J. Hong, S. Kim, S. Park, J. Byun, W. Lee, S. Jeon, S. Hong, B. Kim, Y.G. Ahn
{"title":"69 (PB057): A novel and potent MAT2A inhibitor, HM100760, demonstrates antitumor activity in MTAP-deleted cancers","authors":"E.J. Kwak, S.H. Jung, D.J. Hong, S. Kim, S. Park, J. Byun, W. Lee, S. Jeon, S. Hong, B. Kim, Y.G. Ahn","doi":"10.1016/j.ejca.2024.114596","DOIUrl":"10.1016/j.ejca.2024.114596","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
43 (PB031): MBT-C101, a first-in-class, selective, and potent HSP90 chaperonemediated degrader of PI3Ka 43(PB031):MBT-C101,一种由 HSP90伴侣介导的 PI3Ka 降解剂,具有一流的选择性和效力
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114571
H.S. Choi, I. Shin, S. Kang, J. Hong, Y.C. Kim, A. Jang, J. Yoon, T. Sim
{"title":"43 (PB031): MBT-C101, a first-in-class, selective, and potent HSP90 chaperonemediated degrader of PI3Ka","authors":"H.S. Choi, I. Shin, S. Kang, J. Hong, Y.C. Kim, A. Jang, J. Yoon, T. Sim","doi":"10.1016/j.ejca.2024.114571","DOIUrl":"10.1016/j.ejca.2024.114571","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
45 (PB033): Assessing the predictive value of genomic drivers for targeted therapy in glioblastoma: Insights from a pre-clinical platform 45 (PB033):评估基因组驱动因素对胶质母细胞瘤靶向治疗的预测价值:临床前平台的启示
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114573
A. Decarvalho, O. Nuga, Y. Meng, A. Berezovsky, L. Poisson, J. Snyder, I. Datta
{"title":"45 (PB033): Assessing the predictive value of genomic drivers for targeted therapy in glioblastoma: Insights from a pre-clinical platform","authors":"A. Decarvalho, O. Nuga, Y. Meng, A. Berezovsky, L. Poisson, J. Snyder, I. Datta","doi":"10.1016/j.ejca.2024.114573","DOIUrl":"10.1016/j.ejca.2024.114573","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信